Advertisement

Topics

Ipsen Biopharmaceuticals Inc. Company Profile

14:37 EDT 22nd June 2018 | BioPortfolio


News Articles [289 Associated News Articles listed on BioPortfolio]

Ipsen presents a range of data on Dysport in different therapy areas

Ipsen’s US-based biotech arm, Ipsen Biopharmaceuticals, says it will present data on Dysport (abobotulinumtoxinA)…

Ipsen Announces Clinical Data to Be Presented at ASCO Demonstrating Its Commitment to Patients ...

IpsenMediaIan WeatherheadVice President, Corporate External Communications+44 (0) 1753 627733ian.weatherhead@ipsen.comorBrigitte Le GuennecSenior Manager, Global External Communications+...

Ipsen inks research collaboration with UK firm

French drugmaker Ipsen has entered into a strategic agreement to develop and commercialize innovative…

Ipsen Dreams Of Capital Position In Oncology

Ipsen's chief medical officer Sotirios Stergiopoulos talks about the company's R&D and licensing strategy that he hopes will push Ipsen's...   

End-Year IPSEN Liquidity Contract Statement Entered into with NATIXIS

Regulatory News: Under the liquidity contract entered into between IPSEN and NATIXIS, the following resources were listed in the liquidity account as at December 31, 2017: 19 647 IPSEN shares 2,46...

NICE recommends Ipsen drug for medullary thyroid cancer

Ipsen’s good day has got even better with news that the National Institute for Health and Care Excellence…

Arix Bioscience and Ipsen Sign a Strategic Agreement to Develop and Commercialise Innovative ...

Arix Bioscience plcCharlotte Parry, +44 (0)20 7290 1072Investor Relations Managercharlotte@arixbioscience.comorConsilium Strategic CommunicationsMary-Jane Elliott, Jessica Hodgson, ...

Thyroid cancer drugs from Ipsen, Bayer, Eisai get NICE backing

Ipsen's Cometriq, or cabozantinib, was recommended by the National Institute for Health and Care Excellence for funding by th -More- 

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Thrombin human [Ethicon, Inc]

These highlights do not include all the information needed to use EVITHROM safely and effectively. See full prescribing information for EVITHROM.EVITHROM, Thrombin, Topical (Human)For Topical Use Only...

Somatuline depot [Beaufour Ipsen Pharma SAS]

Somatuline Depot (lanreotide) Injection

PubMed Articles [31 Associated PubMed Articles listed on BioPortfolio]

The importance of biosimilars medicines for private and statutory health insurance.

Patented biopharmaceuticals generate huge costs for private and statutory health insurance. Exactly ten years ago, off-patent biopharmaceuticals, also referred to as 'biosimilars medicines', became av...

Surfactants as Stabilizers for Biopharmaceuticals: An Insight into the Molecular Mechanisms for Inhibition of Protein Aggregation.

Surfactants are common stabilizers, often added to biopharmaceuticals formulations, but the mechanisms at the basis of their activity are unclear. The aim of this work is to provide insight into the m...

Next Generation Biopharmaceuticals: Product Development.

Therapeutic proteins show a rapid market growth. The relatively young biotech industry already represents 20 % of the total global pharma market. The biotech industry environment has traditionally bee...

Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder.

Photodynamic diagnosis using the optical imaging agent hexaminolevulinate (HAL, Hexvix®, Ipsen Pharma GmbH, Ettlingen, Germany) as an adjunct to white light cystoscopy (WLC) during the initial transu...

Development and validation of a bioassay to evaluate binding of adalimumab to cell membrane-anchored TNFα using flow cytometry detection.

Physicochemical and structural properties of proteins used as active pharmaceutical ingredients of biopharmaceuticals are determinant to carry out their biological activity. In this regard, the assays...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Administration of GnRH Antagonist to Oocyte Donation Recipients

This prospective and randomized study was performed to evaluate whether the replacement of GnRH agonist by a GnRH antagonist in oocyte donation recipients during endometrial preparation h...

Nicotine Vaccination and Nicotinic Receptor Occupancy

This is a molecular imaging research study designed to examine how much nicotine gets into the brain before and after vaccination with NicVAX, a nicotine vaccine developed by Nabi Biopharm...

Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders

The purpose of this study is to compare ovulation induction using a flexible GnRH antagonist protocol and flare up GnRH agonist protocol in IVF patients with poor response to ovarian stimu...

A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine

Haemophilus influenza type b (Hib) remains a serious global health threat associated with high mortality and morbidity in young children. In China, The overall impact of Hib-related infect...

Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients

The purpose of this study is to compare pregnancy rates and the occurrence of OHSS in PCOS patients who were treated with GnRH agonist and GnRH antagonist protocols ovarian stimulation dur...

Companies [197 Associated Companies listed on BioPortfolio]

Ipsen Biopharmaceuticals Inc.

Ipsen N.A.

Ipsen is a global specialty-driven pharmaceutical company with total sales exceeding €1.2 billion in 2013. Ipsen’s ambition is to become a leader in specialty healthcare...

Ipsen S.A.

Ipsen is a global biopharmaceutical group, with sales exceeding 1 billion euros in 2009. The Group has total worldwide staff of more than 4,400 employees, of which nearly 900 cont...

The Fondation IPSEN

Established in 1983 under the aegis of the Fondation de France, the ambition of the Fondation IPSEN is to initiate a reflection about the major scientific issues of the forthcomin...

Ipsen

Ipsen is a global biopharmaceutical group with total sales in excess of 1 billion euros in 2009, and total worldwide staff of more than 4,400. Its strategy is based on fast growin...

More Information about "Ipsen Biopharmaceuticals Inc." on BioPortfolio

We have published hundreds of Ipsen Biopharmaceuticals Inc. news stories on BioPortfolio along with dozens of Ipsen Biopharmaceuticals Inc. Clinical Trials and PubMed Articles about Ipsen Biopharmaceuticals Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ipsen Biopharmaceuticals Inc. Companies in our database. You can also find out about relevant Ipsen Biopharmaceuticals Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record